| Full Name | Chana Silver |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 8 Chelsea Ct, Lakewood, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033613906 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 26NR14426900 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Chana Silver, 8 Chelsea Ct, Lakewood, NJ 08701-5345 Ph: () - | Chana Silver, 8 Chelsea Ct, Lakewood, NJ 08701-5345 Ph: (732) 278-0711 |
News Archive
Infinity Pharmaceuticals, Inc., an innovative drug discovery and development company, and Intellikine, Inc., a leader in the development of small molecule drugs targeting the PI3K/mTOR pathway, today announced an agreement under which Infinity obtained global development and commercialization rights to Intellikine's portfolio of inhibitors of the delta and gamma isoforms of phosphoinositide-3-kinase.
When it comes to visibility, radiologists, in many cases, are out of sight. They often receive and interpret images from afar, leaving a patient's referring physician or specialist to disclose the findings - and, using the information supplied, answer questions about the diagnosis.
Living in a deprived area increases the risk of violence more sharply for girls than boys, according to a Cardiff University study of former industrial areas.
Isotechnika Pharma Inc. is pleased to announce that it has finalized the Development, Distribution and License Agreement with ILJIN Life Science Co., Ltd., previously announced on November 16, 2010. Isotechnika will now receive the license fee of US$4.5 million plus proceeds of US$2.375 million from ILJIN's purchase of its first tranche of Common Shares from treasury.
In a large, international, randomized trial, initial radiotherapy was compared to temozolomide chemotherapy. A statistically significant difference between the two treatment strategies was not observed for progression-free survival, although radiotherapy was numerically favored. However, molecular tumor characterization may allow the treatment approach to be personalized and one or the other treatment modality to be selected.
› Verified 3 days ago
Mrs. Tirtzah Kaluszyner, FNP Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 484 Somerset Ave, Lakewood, NJ 08701 Phone: 347-525-8534 | |
Caitlyn Sciarrotta, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1306 River Ave, Lakewood, NJ 08701 Phone: 866-387-8100 | |
Yuliya Bilan Yu, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 101 2nd St, Lakewood, NJ 08701 Phone: 732-363-6655 Fax: 732-901-0277 | |
Mrs. Kristy Lynn Defluri, MSN, CRNA Registered Nurse Medicare: Medicare Enrolled Practice Location: 360 Route 70, Lakewood, NJ 08701 Phone: 732-942-9835 | |
Kate Bianchini, APN Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 600 River Ave, Lakewood, NJ 08701 Phone: 732-773-5340 | |
Mrs. Sheva Gluck, CNM Registered Nurse Medicare: Medicare Enrolled Practice Location: 1382 Lanes Mill Rd, Lakewood, NJ 08701 Phone: 732-994-4242 |